QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
QQQ   308.76 (-0.69%)
AAPL   158.28 (-1.23%)
MSFT   276.38 (-1.49%)
META   202.84 (-1.54%)
GOOGL   102.46 (-2.83%)
AMZN   98.04 (-0.09%)
TSLA   191.81 (+0.74%)
NVDA   265.31 (-0.93%)
NIO   8.93 (-1.54%)
BABA   86.12 (-0.90%)
AMD   96.61 (-1.37%)
T   18.87 (+1.40%)
F   11.52 (+0.09%)
MU   59.79 (-2.24%)
CGC   1.88 (-1.05%)
GE   93.31 (+2.12%)
DIS   95.62 (+1.64%)
AMC   4.55 (+1.79%)
PFE   40.22 (-0.42%)
PYPL   73.30 (-0.79%)
NFLX   327.66 (-0.22%)
NASDAQ:HQY

HealthEquity - HQY Stock Forecast, Price & News

$57.69
+1.67 (+2.98%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$57.04
$58.50
50-Day Range
$52.44
$67.41
52-Week Range
$52.27
$79.20
Volume
455,926 shs
Average Volume
822,059 shs
Market Capitalization
$4.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$81.25

HealthEquity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.82 Rating Score
Upside/​Downside
40.8% Upside
$81.25 Price Target
Short Interest
Bearish
3.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.39mentions of HealthEquity in the last 14 days
Based on 15 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
49.07%
From $1.08 to $1.61 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

231st out of 995 stocks

Business Services, Not Elsewhere Classified Industry

35th out of 93 stocks


HQY stock logo

About HealthEquity (NASDAQ:HQY) Stock

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm's offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HQY Stock News Headlines

Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
HealthEquity (HQY) Scheduled to Post Earnings on Tuesday
Biden To Unleash "Choke Point" Operation On America?
Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.
What Makes HealthEquity (HQY) a Good Investment Avenue?
3 Medical Services Stocks to Buy Amid Industry Challenges
Analyst Ratings for HealthEquity
See More Headlines
Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HQY Company Calendar

Last Earnings
12/06/2021
Today
3/27/2023
Next Earnings (Estimated)
6/05/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HQY
Employees
3,695
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$81.25
High Stock Price Forecast
$94.00
Low Stock Price Forecast
$69.00
Forecasted Upside/Downside
+45.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.82
Research Coverage
11 Analysts

Profitability

Net Income
$-44,290,000.00
Pretax Margin
-4.42%

Debt

Sales & Book Value

Annual Sales
$861.75 million
Cash Flow
$2.71 per share
Book Value
$22.40 per share

Miscellaneous

Free Float
82,270,000
Market Cap
$4.74 billion
Optionable
Optionable
Beta
0.80

Key Executives

  • Jon KesslerJon Kessler
    President, Chief Executive Officer & Director
  • Tyson Murdock
    Chief Financial Officer & Executive Vice President
  • Elimelech Rosner
    Chief Technology Officer & Executive VP
  • Jody Dietel
    Senior Vice President-Compliance & Regulatory News
  • Delano LaddDelano Ladd
    Secretary, Executive VP & General Counsel













HQY Stock - Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HQY shares.
View HQY analyst ratings
or view top-rated stocks.

What is HealthEquity's stock price forecast for 2023?

11 equities research analysts have issued twelve-month target prices for HealthEquity's shares. Their HQY share price forecasts range from $69.00 to $94.00. On average, they anticipate the company's share price to reach $81.25 in the next twelve months. This suggests a possible upside of 45.0% from the stock's current price.
View analysts price targets for HQY
or view top-rated stocks among Wall Street analysts.

How have HQY shares performed in 2023?

HealthEquity's stock was trading at $61.64 on January 1st, 2023. Since then, HQY shares have decreased by 9.1% and is now trading at $56.02.
View the best growth stocks for 2023 here
.

When is HealthEquity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, June 5th 2023.
View our HQY earnings forecast
.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) announced its quarterly earnings results on Monday, December, 6th. The company reported $0.35 EPS for the quarter, meeting analysts' consensus estimates of $0.35. The firm earned $180 million during the quarter, compared to the consensus estimate of $185.44 million. HealthEquity had a positive trailing twelve-month return on equity of 3.50% and a negative net margin of 3.03%. The business's revenue for the quarter was up .3% on a year-over-year basis. During the same quarter last year, the business posted $0.30 EPS.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity updated its FY 2024 earnings guidance on Wednesday, March, 22nd. The company provided earnings per share guidance of $1.74-$1.87 for the period, compared to the consensus estimate of $1.77. The company issued revenue guidance of $960.00 million-$975.00 million, compared to the consensus revenue estimate of $961.58 million.

What is Jon Kessler's approval rating as HealthEquity's CEO?

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by many different retail and institutional investors. Top institutional shareholders include William Blair Investment Management LLC (3.53%), JPMorgan Chase & Co. (2.53%), Brown Advisory Inc. (2.35%), Fred Alger Management LLC (1.87%), Geode Capital Management LLC (1.85%) and ArrowMark Colorado Holdings LLC (1.78%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten.
View institutional ownership trends
.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HealthEquity's stock price today?

One share of HQY stock can currently be purchased for approximately $56.02.

How much money does HealthEquity make?

HealthEquity (NASDAQ:HQY) has a market capitalization of $4.74 billion and generates $861.75 million in revenue each year. The company earns $-44,290,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis.

How many employees does HealthEquity have?

The company employs 3,695 workers across the globe.

How can I contact HealthEquity?

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for the company is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005.

This page (NASDAQ:HQY) was last updated on 3/27/2023 by MarketBeat.com Staff